NLRP3 and diabetes mellitus: For example, metformin, a first-line drug for diabetes treatment, inhibited the activation of NLRP3 inflammasome and cardiomyocyte pyroptosis (209–211), reducing myocardial ischemia-reperfusion injury (210).